Inhibition of lung adenocarcinoma cells by insulin-like growth factor-I receptor and Kirsten rat sarcoma mutations: A mutation analysis with antisense oligodeoxynucleotide

BACKGROUND: Kirsten rat sarcoma (KRAS) mutations are widespread in lung adenocarcinoma patients. The combined utilization of KRAS antisense oligodeoxynucleotide (ASODN) and insulin-like growth factor-I receptor (IGF-IR) may inhibit the proliferation of A549 cell lines of lung adenocarcinoma. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shaoming, Zhao, Lei, Zhang, Jiahui, Zou, Zhiqiang, Du, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448390/
https://www.ncbi.nlm.nih.gov/pubmed/26273371
http://dx.doi.org/10.1111/1759-7714.12176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448390/
https://www.ncbi.nlm.nih.gov/pubmed/26273371
http://dx.doi.org/10.1111/1759-7714.12176

Ejemplares similares